viernes, 29 de mayo de 2020

Experts decry FDA's decision to halt Seattle Covid-19 study over approvals

Experts decry FDA's decision to halt Seattle Covid-19 study over approvals

Daily Recap

Experts decry FDA’s halting of a high-profile Covid-19 study over approvals

By ERIN BRODWIN


JACQUELYN MARTIN/AP
The FDA said its decision to halt a high-profile study to track the virus' spread came after the researchers failed to secure two types of approval.

No hay comentarios:

Publicar un comentario